Oropharyngeal deposition of 3.5 μm particles inhaled through an elongated mouthpiece

European Respiratory Journal

Volumn 9, Issue 7, 1996, Pages 1556-1559

  Svartengren, K ^a   Anderson, M ^a,b   Svartengren, M ^a,b   Philipson, K ^b   Camner, P ^b  

^a KAROLINSKA UNIVERSITY HOSPITAL   (Sweden)

^b KAROLINSKA INSTITUTE   (Sweden)

Author keywords

aerosol therapy; mouthpiece; upper airways

Indexed keywords

POLITEF;

ADULT; AGED; ARTICLE; ASTHMA; CHRONIC BRONCHITIS; CLINICAL ARTICLE; FEMALE; HUMAN; INHALATION; LUNG FUNCTION TEST; MALE; MEDICAL INSTRUMENTATION; OROPHARYNX; PRIORITY JOURNAL;

ADMINISTRATION, INHALATION; AEROSOLS; ASTHMA; BRONCHITIS; FEMALE; HUMANS; LUNG; MALE; MIDDLE AGED; MUCOCILIARY CLEARANCE; NEBULIZERS AND VAPORIZERS; OROPHARYNX; PARTICLE SIZE;

EID: 0030038286     PISSN: 09031936     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (14)

1. Svartengren M, Anderson M, Bylin G, Philipson K, Camner P. Mouth and throat deposition of 3.6 μm radiolabelled particles in asthmatics. J Aerosol Med 1991; 4: 313-321.
2. Svartengren K, Lindestad P-Å, Svartengren M, Bylin G, Philipson K, Camner P. Deposition of inhaled particles in the mouth and throat of asthmatic subjects. Eur Respir J 1994; 7: 1467-1473.
3. Vogt FC. The incidence of candidiasis with use of inhaled corticosteroids. Ann Allergy 1979; 43: 205-210.
4. Williams AJ, Baghat MS, Stableforth DE, Cayton RM, Shenoi PM, Skinner C. Dysphonia caused by inhaled steroids: recognition of a characteristic laryngeal abnormality. Thorax 1983; 38: 813-821.
5. Svartengren K, Lindestad P-Å, Svartengren M, Philipson K, Bylin G, Camner P. Added external resistance reduces oropharyngeal deposition and increases lung deposition of aerosol particles in asthmatics. Am J Respir Crit Care Med 1995; 152: 32-37.
6. Dolovich M, Ruffin R, Corr D, Newhouse MT. Clinical evaluation of a simple demand inhalation MDI aerosol delivery device. Chest 1983; 84: 36-41.
7. Quanjer PH, ed. Standardized lung function testing. Report Working Party "Standardization of Lung Function Tests". European Coal and Steel Community. Eur Respir J 1993; Suppl. 16: 5-40.
8. Camner P. The production and use of test aerosols for studies of human tracheobronchial clearance. Environ Physiol Biochem 1971; 1: 137-154.
9. Philipson K. Monodisperse labelled aerosols for studies of lung clearance. In: Abstracts of Uppsala. Dissertations from the Faculty of Science, Uppsala, Sweden, 1977; 433: 1-36.
10. Svartengren M, Falk R, Linnman L, Philipson K, Camner P. Deposition of large particles in human lung. Exp Lung Res 1987; 12: 75-88.
11. Lippmann M, Albert RE, Peterson HT. The regional deposition of inhaled aerosols in man. In: Walton WH, ed. Inhaled particles. III. Surrey, Unwin Bros Ltd, 1971; pp. 105-120.
12. Stahlhofen W, Rudolf G, James AC. Intercomparison of experimental regional aerosol deposition data. J Aerosol Sci 1989; 2: 285-308.
13. Anderson M, Svartengren M, Philipson K, Camner P. Deposition in man of particles inhaled in air or helium- oxygen mixture at different flow rates. J Aerosol Med 1990; 3: 209-216.
14. Svartengren M, Anderson M, Philipson K, Camner P. Human lung deposition of particles suspended in air or in helium/oxygen mixture. Exp Lung Res 1989; 15: 575-585.